AR and prostate cancer: Besides a cofactor of AR-FL, our data showed PRPF6 also co-activates AR-V7 mediated transcription (Figure 3), indicating that PRPF6 plays an important role in enhancing AR-FL and AR-V7 action in prostate cancer and CRPC.